Peripheral Arterial Disease
"Peripheral Arterial Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Descriptor ID |
D058729
|
| MeSH Number(s) |
C14.907.137.126.307.500 C14.907.617.671
|
| Concept/Terms |
Peripheral Arterial Disease- Peripheral Arterial Disease
- Arterial Disease, Peripheral
- Arterial Diseases, Peripheral
- Disease, Peripheral Arterial
- Diseases, Peripheral Arterial
- Peripheral Arterial Diseases
- Peripheral Artery Disease
- Artery Disease, Peripheral
- Artery Diseases, Peripheral
- Disease, Peripheral Artery
- Diseases, Peripheral Artery
- Peripheral Artery Diseases
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Arterial Disease".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Arterial Disease".
This graph shows the total number of publications written about "Peripheral Arterial Disease" by people in this website by year, and whether "Peripheral Arterial Disease" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 8 | 1 | 9 |
| 2011 | 23 | 4 | 27 |
| 2012 | 31 | 3 | 34 |
| 2013 | 37 | 2 | 39 |
| 2014 | 46 | 8 | 54 |
| 2015 | 53 | 4 | 57 |
| 2016 | 39 | 3 | 42 |
| 2017 | 51 | 3 | 54 |
| 2018 | 53 | 3 | 56 |
| 2019 | 63 | 2 | 65 |
| 2020 | 72 | 2 | 74 |
| 2021 | 43 | 0 | 43 |
| 2022 | 53 | 0 | 53 |
| 2023 | 59 | 2 | 61 |
| 2024 | 38 | 9 | 47 |
Below are the most recent publications written about "Peripheral Arterial Disease" by people in Profiles.
-
Noninvasive therapeutic ultrasound to increase perfusion in chronic limb-threatening ischemia: An early feasibility study. Vasc Med. 2025 Feb; 30(1):20-26.
-
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study. J Comp Eff Res. 2025 Jan; 14(1):e240055.
-
Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease: A Post Hoc Analysis of the BIP Randomized Clinical Trial. JAMA Surg. 2024 Nov 01; 159(11):1262-1270.
-
Outcomes of prosthetic and biological grafts compared to arm vein grafts in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Mar; 81(3):682-692.
-
Association of Anemia and Transfusion with Major Adverse Cardiac Events and Major Adverse Limb Events in Patients Undergoing Open Infrainguinal Bypass. Ann Vasc Surg. 2025 Feb; 111:25-38.
-
Mesenchymal stromal cell therapy (REGENACIP®), a promising treatment option in chronic limb threatening ischemia - a narrative review. Stem Cell Res Ther. 2024 Oct 08; 15(1):352.
-
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial. J Vasc Surg. 2025 Feb; 81(2):366-373.e1.
-
Better limb staging in chronic limb-threatening ischemia: Why it matters. J Vasc Surg. 2024 Oct; 80(4):1224-1225.
-
The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2025 Feb; 81(2):376-385.e3.
-
Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Feb; 81(2):408-416.e2.